KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 153 filers reported holding KURA ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $318 | +23.3% | 34,867 | +43.1% | 0.00% | – |
| Q2 2023 | $258 | -11.3% | 24,368 | +2.6% | 0.00% | – |
| Q1 2023 | $291 | +2.8% | 23,760 | +4.3% | 0.00% | – |
| Q4 2022 | $283 | -99.9% | 22,785 | -14.8% | 0.00% | – |
| Q3 2022 | $366,000 | -47.2% | 26,748 | -29.2% | 0.00% | – |
| Q2 2022 | $693,000 | +15.3% | 37,796 | +1.1% | 0.00% | – |
| Q1 2022 | $601,000 | +94.5% | 37,373 | +69.3% | 0.00% | – |
| Q4 2021 | $309,000 | -58.1% | 22,077 | -43.9% | 0.00% | – |
| Q3 2021 | $737,000 | +7.1% | 39,355 | +19.2% | 0.00% | – |
| Q2 2021 | $688,000 | -23.3% | 33,019 | +4.0% | 0.00% | – |
| Q1 2021 | $897,000 | +15.3% | 31,746 | +33.3% | 0.00% | – |
| Q4 2020 | $778,000 | +21.6% | 23,822 | +14.0% | 0.00% | – |
| Q3 2020 | $640,000 | – | 20,896 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,807,982 | $59,049,000 | 6.41% |
| ACUTA CAPITAL PARTNERS, LLC | 637,500 | $20,821,000 | 5.67% |
| Asymmetry Capital Management, L.P. | 346,518 | $11,317,000 | 5.16% |
| Affinity Asset Advisors, LLC | 260,000 | $8,492,000 | 4.50% |
| EcoR1 Capital, LLC | 1,773,037 | $57,907,000 | 3.11% |
| VR Adviser, LLC | 575,000 | $18,780,000 | 2.76% |
| COMMODORE CAPITAL LP | 133,503 | $4,360,000 | 2.37% |
| Ghost Tree Capital, LLC | 325,000 | $10,615,000 | 2.36% |
| Avoro Capital Advisors LLC | 4,000,000 | $130,640,000 | 2.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 90,000 | $2,939,000 | 1.71% |